DBI — Deutsche Biotech Innovativ AG Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- €4.78m
- €4.76m
Annual balance sheet for Deutsche Biotech Innovativ AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | GAS | GAS | GAS | GAS | GAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.145 | 0.114 | 0.028 | 0.019 | 0.008 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.002 | 0 | 0.108 | 0.001 | 0 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.152 | 0.116 | 0.142 | 0.02 | 0.008 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.002 | 0.001 | 0.007 | 0.005 | 0.002 |
| Long Term Investments | |||||
| Total Assets | 2.2 | 1.95 | 2.28 | 2.27 | 2.16 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.252 | 0.411 | 1.13 | 1.32 | 1.45 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.265 | 0.425 | 1.14 | 1.35 | 1.47 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 1.93 | 1.53 | 1.14 | 0.918 | 0.681 |
| Total Liabilities & Shareholders' Equity | 2.2 | 1.95 | 2.28 | 2.27 | 2.16 |
| Total Common Shares Outstanding |